These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9657008

  • 1. Analysis of loss of heterozygosity in small adenocarcinomas of the lung.
    Yoshioka H, Takeuchi T, Matsuno Y, Yamada T, Shimosato Y, Hirohashi S, Noguchi M.
    Jpn J Clin Oncol; 1998 Apr; 28(4):240-4. PubMed ID: 9657008
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative mutational analysis of pulmonary scar epithelium, bronchioloalveolar carcinomas, and invasive well-differentiated pulmonary adenocarcinomas: a molecular approach to diagnostically challenging cases.
    Sheikh HA, Sasatomi E, Finkelstein S, Yousem SA.
    Am J Surg Pathol; 2005 Oct; 29(10):1267-73. PubMed ID: 16160467
    [Abstract] [Full Text] [Related]

  • 6. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung.
    Yamasaki M, Takeshima Y, Fujii S, Matsuura M, Tagawa K, Inai K.
    Pathol Int; 2000 Nov; 50(11):891-6. PubMed ID: 11107065
    [Abstract] [Full Text] [Related]

  • 7. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
    Dacic S, Finkelstein SD, Yousem SA.
    Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
    [Abstract] [Full Text] [Related]

  • 8. Nuclear p53 accumulation by small-sized adenocarcinomas of the lung.
    Kawasaki M, Noguchi M, Morikawa A, Matsuno Y, Yamada T, Hirohashi S, Kondo H, Shimosato Y.
    Pathol Int; 1996 Jul; 46(7):486-90. PubMed ID: 8870003
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
    Yoshino I, Osoegawa A, Yohena T, Kameyama T, Oki E, Oda S, Maehara Y.
    Respir Med; 2005 Mar; 99(3):308-12. PubMed ID: 15733506
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
    Chmara M, Wozniak A, Ochman K, Kobierska G, Dziadziuszko R, Sosinska-Mielcarek K, Jassem E, Skokowski J, Jassem J, Limon J.
    Anticancer Res; 2004 Mar; 24(6):4259-63. PubMed ID: 15736482
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
    Jian Z, Tomizawa Y, Yanagitani N, Iijima H, Sano T, Nakajima T.
    Pathol Int; 2005 Oct; 55(10):619-25. PubMed ID: 16185291
    [Abstract] [Full Text] [Related]

  • 18. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
    Kitaguchi S, Takeshima Y, Nishisaka T, Inai K.
    Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
    [Abstract] [Full Text] [Related]

  • 19. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF, Mantha GS, Hunt JL, Dacic S.
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.